THeragnostic utilities for neoplastic DisEases of the rectum by MRI guided radiotherapy (THUNDER 2) phase II trial: interim safety analysis

THeragnostic utilities for neoplastic DisEases of the rectum by MRI guided radiotherapy (THUNDER 2) phase II trial: interim safety analysis

Abstract Background The THUNDER-2 phase II single institutional trial investigates the benefits of MRI-guided radiotherapy (MRIgRT) in treating locally advanced rectal cancer (LARC). This study focuses on evaluating the impact of escalating radiation therapy dose in non-responder patients using the...

Full description

Bibliographic Details
Main Authors: Giuditta Chiloiro, Angela Romano, Davide Cusumano, Luca Boldrini, Giulia Panza, Lorenzo Placidi, Elisa Meldolesi, Matteo Nardini, Guenda Meffe, Gianluca Nicolini, Claudio Votta, Luca Indovina, Maria Antonietta Gambacorta
Format: Article
Language:English
Published: BMC 2023-10-01
Series:Radiation Oncology
Subjects:
Magnetic resonance guided Radiation Therapy
Rectal cancer
Chemoradiotherapy
Early Regression Index
Radiomics
Dose escalation
Online Access:https://doi.org/10.1186/s13014-023-02353-x

Internet

https://doi.org/10.1186/s13014-023-02353-x

Similar Items